Eurobio Scientific Société anonyme (ALERS.PA)
EUR 23.8
(-5.93%)
EUR 23.8
(-5.93%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 10.14 Million EUR | -67.33% |
| 2022 | 31.03 Million EUR | -56.88% |
| 2021 | 71.98 Million EUR | -11.36% |
| 2020 | 81.21 Million EUR | 14172.41% |
| 2019 | 569 Thousand EUR | 149.09% |
| 2018 | -1.15 Million EUR | 79.97% |
| 2017 | -5.78 Million EUR | 21.72% |
| 2016 | -7.39 Million EUR | 11.41% |
| 2015 | -8.34 Million EUR | -46.69% |
| 2014 | -5.68 Million EUR | 19.03% |
| 2013 | -7.02 Million EUR | -8.5% |
| 2012 | -6.47 Million EUR | 20.02% |
| 2011 | -8.09 Million EUR | -16.07% |
| 2010 | -6.97 Million EUR | 27.8% |
| 2009 | -9.65 Million EUR | 15.23% |
| 2008 | -11.39 Million EUR | -46.19% |
| 2007 | -7.79 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 6.82 Million EUR | 0.0% |
| 2023 Q4 | 6.07 Million EUR | 0.0% |
| 2023 FY | 10.14 Million EUR | -67.33% |
| 2023 Q2 | 4.06 Million EUR | 0.0% |
| 2022 Q2 | 21.95 Million EUR | 0.0% |
| 2022 FY | 31.03 Million EUR | -56.88% |
| 2022 Q4 | 9.08 Million EUR | 0.0% |
| 2021 Q4 | 33.38 Million EUR | 0.0% |
| 2021 FY | 71.98 Million EUR | -11.36% |
| 2021 Q2 | 38.6 Million EUR | 0.0% |
| 2020 FY | 81.21 Million EUR | 14172.41% |
| 2020 Q4 | 64.22 Million EUR | 0.0% |
| 2020 Q2 | 16.98 Million EUR | 0.0% |
| 2019 FY | 569 Thousand EUR | 149.09% |
| 2019 Q2 | 897 Thousand EUR | 0.0% |
| 2019 Q4 | -329 Thousand EUR | 0.0% |
| 2018 Q4 | -996 Thousand EUR | 0.0% |
| 2018 Q2 | -163 Thousand EUR | 0.0% |
| 2018 FY | -1.15 Million EUR | 79.97% |
| 2017 Q4 | -3.26 Million EUR | 0.0% |
| 2017 FY | -5.78 Million EUR | 21.72% |
| 2017 Q2 | -2.52 Million EUR | 0.0% |
| 2016 Q2 | -4.26 Million EUR | 0.0% |
| 2016 FY | -7.39 Million EUR | 11.41% |
| 2016 Q4 | -3.12 Million EUR | 0.0% |
| 2015 Q4 | -4.82 Million EUR | 0.0% |
| 2015 Q2 | -3.52 Million EUR | 0.0% |
| 2015 FY | -8.34 Million EUR | -46.69% |
| 2014 Q2 | -2.03 Million EUR | 0.0% |
| 2014 Q4 | -3.65 Million EUR | 0.0% |
| 2014 FY | -5.68 Million EUR | 19.03% |
| 2013 Q4 | -3.75 Million EUR | 0.0% |
| 2013 Q2 | -3.27 Million EUR | 0.0% |
| 2013 FY | -7.02 Million EUR | -8.5% |
| 2012 Q2 | - EUR | 100.0% |
| 2012 FY | -6.47 Million EUR | 20.02% |
| 2012 Q4 | - EUR | 100.0% |
| 2012 Q3 | -1.66 Million EUR | 0.0% |
| 2012 Q1 | -1.66 Million EUR | 0.0% |
| 2011 Q4 | - EUR | 100.0% |
| 2011 Q2 | - EUR | 100.0% |
| 2011 FY | -8.09 Million EUR | -16.07% |
| 2011 Q3 | -2.02 Million EUR | 0.0% |
| 2011 Q1 | -2.02 Million EUR | 0.0% |
| 2010 Q1 | -1.74 Million EUR | 0.0% |
| 2010 FY | -6.97 Million EUR | 27.8% |
| 2010 Q4 | - EUR | 100.0% |
| 2010 Q3 | -1.74 Million EUR | 0.0% |
| 2010 Q2 | - EUR | 100.0% |
| 2009 Q1 | -2.41 Million EUR | 15.23% |
| 2009 Q4 | - EUR | 100.0% |
| 2009 Q3 | -2.41 Million EUR | 0.0% |
| 2009 Q2 | -2.41 Million EUR | 0.0% |
| 2009 FY | -9.65 Million EUR | 15.23% |
| 2008 FY | -11.39 Million EUR | -46.19% |
| 2008 Q1 | -2.84 Million EUR | -46.2% |
| 2008 Q2 | -2.84 Million EUR | 0.0% |
| 2008 Q3 | -2.84 Million EUR | 0.0% |
| 2008 Q4 | -2.84 Million EUR | 0.0% |
| 2007 Q4 | -1.94 Million EUR | 0.0% |
| 2007 Q2 | -1.94 Million EUR | 0.0% |
| 2007 Q3 | -1.94 Million EUR | 0.0% |
| 2007 Q1 | -1.94 Million EUR | 0.0% |
| 2007 FY | -7.79 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Affluent Medical SA | -13.06 Million EUR | 177.614% |
| Bluelinea Société Anonyme | -1.61 Million EUR | 728.835% |
| Carmat SA | -52.51 Million EUR | 119.309% |
| Diagnostic Medical Systems S.A. | -2.26 Million EUR | 547.726% |
| Euromedis Groupe | -5.55 Million EUR | 282.484% |
| Ikonisys S.A. | -2.19 Million EUR | 562.272% |
| Implanet S.A. | -6.15 Million EUR | 264.653% |
| Median Technologies SA | -23 Million EUR | 144.08% |
| SpineGuard SA | -3.97 Million EUR | 355.049% |
| Theraclion SA | -3.15 Million EUR | 421.528% |
| Euroapi S.A. | -234.3 Million EUR | 104.328% |
| Guerbet SA | 38.67 Million EUR | 73.776% |
| Ion Beam Applications SA | 5.09 Million EUR | -99.156% |
| Koninklijke Philips N.V. | -115 Million EUR | 108.818% |
| Sequana Medical NV | -29.49 Million EUR | 134.386% |